Clinical Trial

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting
Protocol Amendment History 4 changes
critical Trial completed 2026-08-05
notable Enrollment increased: 55 -> 650 participants 2026-08-05
notable Primary completion moved earlier: 2026-06-30 -> 2025-10-31 2026-08-05
minor Completion moved earlier: 2026-06-30 -> 2025-10-31 2026-08-05
Trial Details
NCT Number NCT06448793
Lead Sponsor Bristol-Myers Squibb
Conditions Non-small Cell Lung Cancer (NSCLC)
Enrollment 650 participants
Start Date 2024-11-25
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04